HOP Civil

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Dermatomyositis and polymyositis (myositis)1 trial
• Idiopathic pulmonary fibrosis1 trial
• Lung cancer1 trial

Phase

• Phase 32 trials
• Phase 11 trial
• Phase 21 trial

Status

• Completed3 trials
• Not yet recruiting1 trial

Lead sponsor

• Boehringer Ingelheim4 trials

Running trials

• Not yet recruiting

  A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies

  NCT07789015· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Dermatomyositis and polymyositis (myositis)1 recruiting

Closed trials

• Completed

  A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

  NCT05321069· Phase 3· Boehringer Ingelheim· Source

• Completed

  A Study to Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3)

  NCT04771273· Phase 2· Boehringer Ingelheim· Source

• Completed

  A Study to Test Different Doses of BI 836880 Combined With Ezabenlimab in Patients With Advanced Non-small Cell Lung Cancer Followed by Other Types of Advanced Solid Tumours

  NCT03468426· Phase 1· Boehringer Ingelheim· Source